• Citer

Combined treatment with buserelin and tamoxifen in premenopausal metastatic breast cancer: a randomized study.

par Klijn, J G;Beex, Louk;Mauriac, L;van Zijl, J A;Veyret, C;Wildiers, J;Jassem, J.;Piccart-Gebhart, Martine ;Burghouts, J;Becquart, Dominique;Seynaeve, Carine;Becquart, D;Duchateau, L
Référence Journal of the National Cancer Institute, 92, 11, page (903-911)
Publication Publié, 2000-06

Article révisé par les pairs

• Détails
• Contenu

Titre:	Combined treatment with buserelin and tamoxifen in premenopausal metastatic breast cancer: a randomized study.
Auteur:	Klijn, J G; Beex, Louk; Mauriac, L; van Zijl, J A; Veyret, C; Wildiers, J; Jassem, J.; Piccart-Gebhart, Martine; Burghouts, J; Becquart, Dominique; Seynaeve, Carine; Becquart, D; Duchateau, L
Informations sur la publication:	Journal of the National Cancer Institute, 92, 11, page (903-911)
Statut de publication:	Publié, 2000-06
Sujet CREF:	Sciences bio-médicales et agricoles
MeSH keywords:	Adult
	Antineoplastic Agents, Hormonal -- therapeutic use
	Breast Neoplasms -- blood
	Breast Neoplasms -- drug therapy
	Buserelin -- therapeutic use
	Disease-Free Survival
	Drug Therapy, Combination
	Estradiol -- blood
	Estrogen Receptor Modulators -- therapeutic use
	Female
	Gonadotropin-Releasing Hormone -- blood
	Humans
	Menstrual Cycle -- drug effects
	Middle Aged
	Premenopause
	Prognosis
	Prospective Studies
	Risk Factors
	Selective Estrogen Receptor Modulators -- therapeutic use
	Survival Analysis
	Tamoxifen -- therapeutic use
	Time Factors
	Treatment Outcome
Note générale:	Clinical Trial
	Journal Article
	Multicenter Study
	Randomized Controlled Trial
Langue:	Anglais
Identificateurs:	urn:issn:0027-8874
	info:pmid/10841825